Alchemi Wealth LLC purchased a new stake in shares of Columbia Research Enhanced Core ETF (NYSEARCA:RECS – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 109,047 shares of the company’s stock, valued at approximately $4,454,000. Columbia Research Enhanced Core ETF accounts for about 2.4% of Alchemi Wealth LLC’s portfolio, making the stock its 7th biggest position. Alchemi Wealth LLC owned approximately 0.09% of Columbia Research Enhanced Core ETF as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also bought and sold shares of RECS. Jane Street Group LLC raised its holdings in Columbia Research Enhanced Core ETF by 49,303.3% during the second quarter. Jane Street Group LLC now owns 16,658,312 shares of the company’s stock valued at $612,859,000 after acquiring an additional 16,624,593 shares during the period. LPL Financial LLC increased its holdings in shares of Columbia Research Enhanced Core ETF by 26.6% in the fourth quarter. LPL Financial LLC now owns 17,374,371 shares of the company’s stock worth $709,569,000 after purchasing an additional 3,650,956 shares during the last quarter. Ameriprise Financial Inc. increased its holdings in shares of Columbia Research Enhanced Core ETF by 22.3% in the second quarter. Ameriprise Financial Inc. now owns 12,963,845 shares of the company’s stock worth $476,940,000 after purchasing an additional 2,368,065 shares during the last quarter. Bank of America Corp DE increased its holdings in shares of Columbia Research Enhanced Core ETF by 32.0% in the third quarter. Bank of America Corp DE now owns 5,842,374 shares of the company’s stock worth $235,740,000 after purchasing an additional 1,417,178 shares during the last quarter. Finally, Raymond James Financial Inc. increased its holdings in shares of Columbia Research Enhanced Core ETF by 27.8% in the third quarter. Raymond James Financial Inc. now owns 4,049,122 shares of the company’s stock worth $163,382,000 after purchasing an additional 881,172 shares during the last quarter.
Columbia Research Enhanced Core ETF Trading Up 0.5%
Shares of RECS stock opened at $43.27 on Friday. Columbia Research Enhanced Core ETF has a 12-month low of $35.25 and a 12-month high of $44.01. The stock’s 50-day moving average price is $42.25 and its 200-day moving average price is $41.25. The stock has a market capitalization of $5.55 billion, a price-to-earnings ratio of 22.01 and a beta of 0.93.
Columbia Research Enhanced Core ETF Company Profile
The Columbia Research Enhanced Core ETF (RECS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000. The index uses multifactor selection and market cap weighting. RECS was launched on Sep 25, 2019 and is managed by Columbia.
Featured Articles
- Five stocks we like better than Columbia Research Enhanced Core ETF
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for Columbia Research Enhanced Core ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Columbia Research Enhanced Core ETF and related companies with MarketBeat.com's FREE daily email newsletter.
